Inhibitory effects of 6-O-acylated l-ascorbic acids possessing a straight- or branched-acyl chain on Epstein–Barr virus activation
Authors:
- Shinichi UesatoSUShinichi Uesato
- Yutaka KitagawaYKYutaka Kitagawa
- Tomohiro KaijimaTKTomohiro Kaijima
- Harukuni TokudaHTHarukuni Tokuda
- Masao OkudaMOMasao Okuda
- Xiao Yang MouXMXiao Yang Mou
- Teruo MukainakaTMTeruo Mukainaka
- Hoyoku NishinoHNHoyoku Nishino
- 1 May 2001
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 166 (2) , 143-146
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 5 references indexed in Scilit:
- Antitumor promoting activities of 3-O-acyl-(−)-epigallocatechinsBioorganic & Medicinal Chemistry Letters, 2000
- Anti-tumor-promoting effects of phenylpropanoids on Epstein–Barr virus activation and two-stage mouse skin carcinogenesisCancer Letters, 1999
- Anti-tumor-promoting effects of 8-substituted 7-methoxycoumarins on Epstein–Barr virus activation assayCancer Letters, 1999
- Average intake of anti‐oxidant (PRO)vitamins and subsequent cancer mortality in the 16 cohorts of the seven countries studyInternational Journal of Cancer, 1995
- Pharmaceutucal Studies on Ascorbic Acid Derivatives. I. : Syntheses of Esters of Ascorbic Acid and Their Physicochemical PropertiesYAKUGAKU ZASSHI, 1966